Loading paragraph...
Today's Biggest Stock Losers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| AQST | Aquestive Therapeutics | $3.81 | -$2.40 | -38.65% | 19.8M | $758M | $2.12$7.55 |
| BBNX | Beta Bionics | $20.31 | -$11.68 | -36.51% | 107.1K | $1.4B | $8.89$32.71 |
| ACON | Aclarion | $5.19 | -$2.98 | -36.48% | 1.3M | $5.5M | $4.32$1,241.88 |
| STSS | Sharps Technology | $1.93 | -$0.66 | -25.48% | 2.8M | $75M | $1.65$630.00 |
| EMAT | Evolution Metals & Technologies | $13.80 | -$3.21 | -18.87% | 69.2K | $48M | $7.05$24.37 |
| ATRA | Atara Biotherapeutics | $14.25 | -$3.19 | -18.29% | 338.2K | $126M | $5.01$19.15 |
| SMX | Smx (Security Matters) Public | $23.32 | -$4.84 | -17.19% | 822.6K | $30M | $3.12$34,234.80 |
| ASPC | A Spac III Acquisition Corp. | $17.77 | -$3.60 | -16.85% | 57K | $50M | $9.97$63.98 |
| SLS | Sellas Life Sciences Group | $3.27 | -$0.60 | -15.41% | 7.8M | $550M | $0.85$5.18 |
| NVVE | Nuvve | $4.07 | -$0.64 | -13.59% | 798.8K | $6.2M | $1.98$200.80 |
Related Articles
Featured Article
Can Evolus Disrupt the Botox Market?
Brett Schafer|Jul 3, 2021
This small-cap stock is going after a billion-dollar market.
After a Label Expansion, Is This Under-the-Radar Biotech a Buy?
James Halley|Mar 27, 2021
This healthcare stock just got great news from the Food and Drug Administration.
2 Steps to Biotech Success: Good Data, Then Raise Capital
Brian Orelli, PhD|Dec 23, 2020
Companies that don't do the second step won't last long in this industry.
![Biotech_Stocks_Step_1_Good_Data,_Step_2_Raise_Capital[1]](https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F605702%2Fbiotech_stocks_step_1_good_data_step_2_raise_capital1.jpg&w=384&op=resize)
Advertisement
These 2 Pharma Stocks Could Be Top Stocks in 2020
Amar Khatri|Jul 6, 2020
These pharma stocks are undervalued, and could be solid picks over the long term.
2 Biotech Stocks That Could Soar in 2020
Amar Khatri|Jul 1, 2020
These companies offer promising pipelines that could deliver in the long term.
2 Top Biotech Stocks Under $10
George Budwell, PhD|Apr 27, 2020
Amarin and Atara Biotherapeutics could both be diamonds in the rough.
2 Incredibly Cheap Cancer Stocks to Buy Now
George Budwell, PhD|Jan 30, 2020
These two cancer stocks are trading at a pittance compared to their long-term value propositions.
Where Will Gilead Sciences Spend Its Cash?
George Budwell, PhD|May 7, 2019
Atara Biotherapeutics and Exelixis might be top takeover targets for the biotech giant.
Pacira BioSciences Rocks in Q1 With Strong Momentum for Pain Drug Exparel
Keith Speights|May 2, 2019
The small drugmaker posted record sales for its flagship drug in the first quarter.
2 Best Biotech Buyout Plays
George Budwell, PhD|Apr 23, 2019
Atara Biotherapeutics and Crispr Therapeutics stand out as strong takeover candidates. Here's why.
